Figures
Abstract
Nasopharyngeal transmission of Streptococcus pneumoniae is a prerequisite for the development of pneumococcal diseases. Previous studies have reported a relationship between respiratory viruses and S. pneumoniae infections. However, there are few studies on this issue among healthy children. This study aimed to examine the relationships between these agents in healthy children from Southern Brazil. This cohort study included 229 nasopharyngeal samples collected from children aged 18–59 months at baseline. S. pneumoniae was detected using bacterial culture, whereas respiratory viruses were identified using quantitative polymerase chain reaction. A questionnaire was used at the time of sample collection and medical records were reviewed 14 days after participant inclusion. The prevalence of pneumococcal carriage was 63.7% (146/229), while respiratory viruses were detected in 49.3% (113/229) of the children. Respiratory viruses were more frequently found among pneumococcal carriers than among non-carriers (54.4% vs. 39.7%, p = 0.033). Additionally, rhinovirus (hRV) was more frequent among the pneumococcal carriers (39% vs. 21.7%, p = 0.012), and the presence of human bocavirus (hBOV) alone was associated with the absence of pneumococcal carriage (2.7% vs. 10.8%, p = 0.016). No differences were found in the frequency of pneumococcal carriage, respiratory virus detection, or the co-occurrence of clinical symptoms and diagnosis in the participants 14 days after specimen collection. Our findings revealed a positive relationship between pneumococcal carriage and respiratory virus detection, particularly for hRV. However, we did not observe a relationship between nasopharyngeal respiratory viruses and pneumococci detection during medical appointments, respiratory symptoms, or diseases. This study was one of the first investigations in Latin America to explore the relationship between respiratory viruses and pneumococcal carriage in a healthy children.
Citation: Pizzutti K, Comerlato J, Oliveira DVd, Robaina A, Mott MP, Vieira PUP, et al. (2025) Nasopharyngeal carriage of Streptococcus pneumoniae among Brazilian children: Interplay with viral co-infection. PLoS ONE 20(1): e0316444. https://doi.org/10.1371/journal.pone.0316444
Editor: Jairam Meena, Indian Institute of Technology BHU Varanasi, INDIA
Received: December 19, 2023; Accepted: December 11, 2024; Published: January 2, 2025
Copyright: © 2025 Pizzutti et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the manuscript and its Supporting Information files
Funding: The author(s) received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Streptococcus pneumoniae (pneumococcus) is a common cause of invasive diseases, such as pneumonia, meningitis, and bacteremia. Since the global introduction of pneumococcal conjugate vaccines (PCV), the incidence of invasive pneumococcal disease (IPD) has declined [1–4]. However, this disease remains among the leading causes of morbidity and mortality in children under five years old and the elderly, particularly in low- and middle-income countries [5]. Global estimates indicate that pneumococcus caused 8.9 million cases of pneumonia in children aged 1–59 months and 294,000 deaths among children aged 1–59 months worldwide in 2015 [6]. Although conjugate vaccines are available, Brazil continues to experience a high annual pneumonia rate, primarily based on the number of hospitalizations for pneumonia in children during their first year of life, reaching 3,433 per 100,000 inhabitants [7]. Pneumococcal vaccine coverage in Brazil in 2017 was approximately 92%, with rates reaching 93.7% in southern Brazil [8].
Nasopharyngeal pneumococcal colonization (PNC) is a prerequisite for pneumococcal disease and facilitates transmission within the community [9, 10]. Various factors influence pneumococcal carriage, including age, nursery attendance, number of siblings, and vaccination [11, 12]. Viruses may also affect the prevalence of pneumococcal colonization. Recent studies have reported an increase in pneumococcal density when respiratory viruses were simultaneously present in the nasopharynx [13–16]. Increased density promotes pneumococcal invasion and the severity of IPD [12]. However, no specific value was established to reliably predict the possibility of pneumococcal pneumonia [17–20].
These viruses primarily cause acute respiratory infections (ARI) during childhood. During viral infection, PNC is associated with increased viral activity and progression to ARI [20–23]. Interactions between respiratory viruses and pneumococci increase the severity of respiratory illnesses [13, 14, 21, 24]. Additionally, the role of various viruses in creating conditions for bacterial superinfections, such as pneumococcal pneumonia, was previously documented [25, 26]. Epidemiological studies have shown that an increase in certain viruses among children is associated with higher rates of pediatric admission owing to IPD [24, 26, 27]. Furthermore, mechanistic studies have revealed that viruses increase bacterial adhesion, translocation, and persistence [28–31].
The relationship between viral infections and pneumococcal diseases has been thoroughly examined. However, there information regarding the interaction between respiratory viruses and pneumococcal carriages in healthy children is lacking [14, 15]. Several studies have explored the heightened severity of infectious diseases when these pathogens interact [13–16, 21, 31]. However, there is a notable gap in data concerning children who are carriers of both pneumococcal and viral pathogens. This study aimed to examine the relationship between respiratory viruses, pneumococcal carriage, and the development of respiratory diseases in Brazilian children aged 18–59 months.
Materials and methods
Study population and data collection
We conducted a cohort study to investigate pneumococcal carriage and respiratory viruses in the nasopharynx of children aged 18–59 months. The participants were recruited between February 2018 and October 2019 from Veranópolis City, Rio Grande do Sul, Brazil. The city had an estimated population of 26,533 inhabitants in 2017, 781 of whom were children aged 18–59 months old. This age group included children who had complete vaccination schedules. Participants were recruited through schools, telephone calls, and radio announcements in the city. All legal guardians provided written informed consent at the time of specimen collection using an informed consent form. If siblings were included, the legal guardian provided consent for both children. All participants were considered healthy enough to attend school and maintain a normal routine at the time of data collection. Individuals were deemed ineligible for enrollment if they had been diagnosed with acute respiratory disease or had been hospitalized in the week preceding specimen collection at enrollment. Health professionals trained for the study collected a nasopharyngeal specimen and conducted structural interviews with legal guardians to collect data on demographic characteristics, pneumococcal vaccination history, and the presence of symptoms, such as cough, coryza/congestion, or sore throat. The children did not undergo medical examinations.
The medical records of each participant were accessed in November 2019 and analyzed for up to 14 days after collection. This period was selected because respiratory disease and/or symptoms following co-infection with pneumococcus and respiratory viruses appear to manifest within a period of 1 to 2 weeks [15, 16, 20–22]. Data were retrieved from 15 different health services covering the entire city to identify symptoms and relevant outcomes. Symptoms, including cough, nasal congestion/coryza, sore throat, and fever, were considered. These outcomes were categorized according to the clinical syndromes: community-acquired pneumonia, sinusitis, acute otitis media, tonsillopharyngitis, asthma, and upper and lower ARI. All relevant outcomes were recorded in the database, with each occurrence counted only once per child, even if the same outcome was presented multiple times to the same participant. If there were no records of visits for a child, it was assumed that the child did not seek medical care for outcomes of interest during that period. The diagnoses documented in the records were based on clinical criteria established by each medical professional. Subsequently, each case was thoroughly reviewed by a pediatric researcher in our team (JCS).
Respiratory sample collection, and testing
Nasopharyngeal specimen collection followed the Specimen Collection Guidelines–CDC protocol [32], utilizing FLOQswab® (516CS01. Copan®, Murrieta, CA, USA), which were immediately placed in vials containing 1.0 mL skim milk, tryptone, glucose, glycerol transport medium and stored on dry ice. All nasopharyngeal specimens were sent to the Federal University of Health Sciences of Porto Alegre. Subsequently, the specimens were transferred to a freezer at -80°C until culture. Pneumococcal isolation and identification were conducted using a previously described protocol [32], involving broth enrichment, followed by growth on a blood agar base.
The viral nucleic acid was extracted from NP specimens using the MagMAX™ Pathogen RNA/DNA Kit (Applied Biosystems® by Life Technologies, Carlsbad, CA, USA) following the manufacturer’s recommendations. The 18S rRNA gene was selected as an internal control to monitor nucleic acid extraction efficiency and potential PCR inhibition [33]. Ten respiratory viruses were screened: respiratory syncytial virus, influenza viruses (INF) A and B, metapneumovirus (MPV), human rhinovirus (hRV), adenovirus (ADV), human parainfluenza virus (hPIV) 1–3, and human bocavirus (hBOV). The quantitative PCR assays used are detailed in S1 Table and have been previously described [34–36].
Ethical approval
The study was approved by the Ethics Committees of Federal University of Health Sciences of Porto Alegre (approval numbers 2.176.785 and 3.374.087) and the Federal University of Rio Grande do Sul (Hospital de Clínicas de Porto Alegre; approval numbers 2.106.235 and 3.063.051).
Statistical analysis
The sample size was calculated considering the Brazilian PNC prevalence of 62.3% [37], with a 95% confidence level (CI) and an acceptable error of 5.3%, resulting in a required sample size of 229 children. Categorical variables were analyzed using frequencies and percentages, whereas continuous variables were summarized using means and standard deviations. The association between pneumococcal carriage and/or respiratory virus detection and age was assessed using the Kruskal–Wallis test followed by post-hoc Dunn’s pairwise tests and Bonferroni correctionThe association of pneumococcal carriage with demographic data, symptoms, medical record analysis, and respiratory viruses was assessed using chi-square or Fisher’s exact tests. Odds ratios and multinomial logistic regression, where applicable. The multinomial logistic regression included four outcome categories including ‘agent identified’ (reference group), ‘pneumococcal carriage only, ‘ ‘respiratory virus detection only,’ and ‘co-occurrence.’ The exposure variables included age (months), male sex, lack of sleep, season, and any illness symptoms at enrollment. A chi-square or Fisher’s exact test was carried out on the symptoms at the time of collection, and each virus was investigated using two cut-off points: Ct <30 (high levels only) and <35 (any level); Ct >35 was considered negative. Results with a p-value < 0.05 were considered statistically significant. Statistical analyses were performed using SPSS software (IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp.).
Results
In 2017, Veranópolis City had an estimated 781 children aged 18–59 months. A total of 229 children were included in this cross-sectional study (Fig 1). Five children were excluded from the medical record evaluation, resulting in 224 children included in the cohort study. The study population comprised equal numbers of females and males. Siblings were not clustered in the analyses because of the small number of participants under this condition (only 10 participants).
ICF, informed consent form.
The prevalence of pneumococcal carriage was 63.7% (146/229, CI 95%: 57.4–69.8%) and 49.3% (113/229, CI 95%: 42.9–55.8%) for respiratory viruses. Respiratory viruses were more frequently found among pneumococcal carriers (54.4% (80/146) vs. non-carriers [39.7% (33/83); p = 0.033]). CI95%: 46.7–62.7%). Co-occurrence rate of 34.9% (80/229, CI 95%: 29.0–41.3%). As shown in Table 1, children who tested positive for viral infection, with or without the co-occurrence of pneumococcus, were younger than pneumococcal carriers (31 and 33 months vs. 42 months; p < 0.001). There was a significant relationship between viral and bacterial co-occurrence and male sex (63.8%; p = 0.004), whereas the absence of the investigated organisms was associated with females (Table 1).
Additionally, multinomial logistic regression analysis of certain demographic data and the presence of pneumococcal carriage, respiratory virus, and co-occurrence was conducted (S2 Table). With each passing month of age, the likelihood of acquiring a respiratory virus decreased by 4% (p = 0.020; OR 0.96, 95% CI 0.92; 0.99), and 5% for co-occurrence (p = 0.003; OR 0.95, 95% CI 0.92; 0.98). The male sex was associated with a higher co-occurrence rate (p = 0.001; OR 3.62, 95% CI 1.64; 7.98). The likelihood of co-occurrence was higher in fall (p = 0.018; OR 5.3, 95% CI 1.33; 21.09), compared with that in spring, which had the highest number of children without microorganisms detected. The symptoms associated with each virus at the time of collection were investigated using two cutoffs: Ct <30 (only high levels) and <35 (any level), as detailed in Table 2. The only symptom associated with the occurrence of any virus was sore throat with any hRV Ct value (p < 0.05).
Various viruses were detected in children with pneumococcal infections. A relationship was observed between total hRV (alone + co-detection) 39% (57/146, p = 0.011) and the detection of any respiratory virus 54.8% (80/146, p = 0.040) with pneumococcal carriage (Table 3). Additionally, the presence of hBOV alone was associated with the absence of pneumococcal carriage (10.8%; p = 0.016). All samples tested negative for INF A and B, as well as for hPIV 1, 2, and 3.
Among the eligible participants for the cohort study, 19.2% (43/224) required medical care within 14 days. Co-occurrence was present in 32.5% (14/43) of children who needed medical care. However, no statistically significant correlation was found between pneumococcal carriage, respiratory virus detection, or co-occurrence in the medical appointments of the participants 14 days after specimen collection (Table 4).
No relationships were found between the frequency of pneumococcal carriage, respiratory virus detection, or co-occurrence and different clinical symptoms and diagnoses of the participants 14 days after the collection of specimens (Table 4). The frequency of each respiratory virus and the symptoms of the children after 14 days of medical care are detailed in S4 Table.
Seasonality could not be reliably determined because of the lack of homogeneity in the sample collection across seasons, as detailed in S5 Table. Samples were collected based on the availability of volunteers, with fewer collections occurring during summer, likely because of school vacations.
Discussion
This study represents an initial investigation in Latin America to explore the relationship between respiratory viruses and pneumococcal infections in healthy children. We found a significant relationship between respiratory viruses, particularly rhinoviruses and pneumococci in children aged 18–59 months in Southern Brazil. However, no association was found with disease development 14 days after exposure to these agents. The prevalence of respiratory viruses was higher in younger children, a finding consistent with previous literature reporting a high viral prevalence in children younger than our study population (< 1 year) [38, 39]. Although our study did not include children under one year of age, we observed a similar relationship between younger age and respiratory viruses in children aged 18–59 months.
Children who were "too sick" were excluded from this study. The recruitment process allowed for the inclusion of children with mild respiratory symptoms as reported by their guardians. Consequently, 108 (47.2%) and 79 (34.5%) children exhibited coryza/congestion and coughing, respectively. Despite the frequency of these symptoms in our study, they were not associated with the detection of the viruses studied. According to the literature, these symptoms are commonly associated with respiratory viruses. Notably, lower Ct levels are often associated with more severe respiratory symptoms and mortality [40]. However, in our study, high Ct levels were observed, which is consistent with the clinical condition of the study group (considered healthy) and the lack of association with symptoms.
An association between hRV and sore throat was identified independent of Ct values, and some studies have demonstrated an association between hRV and sore throat [41, 42]. For instance, in a study conducted on individuals experiencing sore throats, hRV was the most commonly detected pathogen [43]. Moreover, an experimental study involving intranasal inoculation of hRV observed scratchy/sore throat symptoms appearing 10–12 h after the induced inoculation [44]. Notably, these symptom observations were not derived from a medical examination; however, some subjectivity was involved. In the present study, INF and hPIV were not detected. The prevalence of these viruses is typically low (<3%) among asymptomatic children [15, 16] because they interact with their hosts and produce symptoms [45, 46].
No relationship was observed between a specific virus and pneumococcal colonization. However, the detection of more than one virus, especially hRV, is associated with pneumococcal carriage. These findings are consistent with those of Demuri (2018) [15] and Howard (2019) [16], who also reported a relationship between the presence of respiratory viruses and pneumococcal colonization in samples with more than one respiratory virus. In both cited studies, hRV was the most frequent virus involved in the co-occurrence of pneumococcal carriage and significantly influenced the increase in pneumococcal density [15, 16]. There is considerable diversity among studies regarding the age ranges of healthy children. For instance, one study focused on children under three years old [15], while another included children aged four to seven years [16]. Additionally, a study conducted in the Democratic Republic of Congo in children aged 2–60 months reported pneumococcus and viral co-occurrences in 30% of the study population. However, this study did not analyze the co-occurrence of pneumococci and each virus individually [47]. Furthermore, some studies have reported an association between pneumococcus and hRV infection in healthy children. A study conducted in western Australia demonstrated a positive correlation between hRV and pneumococcal carriage in children older than one year [48].
Currently, there is no evidence suggesting an antagonistic relationship between hBOV and pneumococcal carriage. Co-infection with hBOV and pneumococcus has been reported [49–51]. A Brazilian study investigating hBOV-related community-acquired pneumonia in children caused found that pneumococcus was the main bacteria in co-infection cases, with pneumococcus detected in 33% (7/21) of co-infections [52]. Similarly, a Japanese study observed a positive correlation between the co-detection of pneumococcus and hBOV, where 85.7% (12/14) of children tested positive exclusively for both pathogens in otitis media fluid. However, this correlation was not observed in the nasopharynx, as the proportion of pneumococcus was similar between groups of individuals positive and negative for hBOV and other pathogenic bacteria. Notably, pneumococci were the only pathogens present in all but one of the co-detections in hBOV-positive cases, whereas in the nasopharynx, it was mixed with other pathogenic bacteria [53]. This suggests that these pathogens migrated to their target site (otitis media fluid), with the nasopharynx not being the site where the etiological agent was identified. It is essential to highlight that in children without serious diseases, these microorganisms may play an antagonistic role in the colonization of the nasopharynx, potentially suggesting the protection of pneumococcus in the presence of hBOV alone. However, interpretation of the results of both studies was limited by the small number of patients included. Nevertheless, these studies collectively underscore the relevance of pneumococcus and respiratory virus coinfection in disease pathogenesis. Our findings, such as the absence of INF and hPIV in the sampled population, likely reflect the predominance of these viruses in children with more severe symptoms. INF, in particular, is well known for its association with co-infection and increased risk of subsequent severe pneumococcal disease [54, 55]. Further studies are needed to elucidate the mechanisms underlying the interactions between hBOV and pneumococci.
We examined the clinical outcomes of the population 14 days after specimen collection to gain a deeper insight into the relationships between these microorganisms. We focused on medical consultations, but exclusively recorded the symptoms and diagnoses of interest. The importance of viral infections in predisposing individuals to subsequent bacterial infections is well-established. Among healthy children, studies have demonstrated that the presence of respiratory viruses and pneumococci at high densities is a risk factor for subsequent infections [15, 16, 21]. However, our results suggest harmonious coexistence between viruses and pneumococci. Notably, this population had high vaccination coverage for the prevention of pneumococcal diseases. Therefore, the protection conferred by the vaccine may have prevented the development of disease, regardless of the presence of viral agents. In populations with insufficient vaccination coverage, the relationship with the presence of viruses may differ and warrants further investigation.
These observations suggest that pneumococcal carriage is affected by various factors that are poorly understood, with the participation of viruses likely to play a prominent role. Studies investigating the relationship between respiratory viruses and pneumococcal colonization should be approached with caution. There is considerable diversity across studies, including variations in the age of the children studied, specimen collection methods, microbiological and molecular techniques used for pneumococcal detection, viruses studied, and the definition of outcomes (presence or density of pneumococci). Although this diversity may hinder direct comparisons among study results, it underscores the need for additional research that can offer new perspectives on this issue.
This study had unique characteristics and limitations that merit consideration. This is one of the pioneering investigations analyzing the co-occurrence of pneumococcus and various respiratory viruses among children aged 18–59 months, a population that is predominantly vaccinated against pneumococcal diseases. A limitation of our study, similar to other studies, is the use of PCR to detect respiratory viruses in healthy children. Interpretation of the results can be challenging, as detection may indicate prolonged shedding of the virus resulting from a previous episode [16, 56]. Furthermore, although comprehensive, our viral panel did not include other agents that could potentially contribute to pneumococcal colonization, such as seasonal coronaviruses.
In summary, our findings revealed a positive relationship between pneumococcal carriage and multiple respiratory viruses, particularly rhinoviruses, in a population with high vaccination coverage. However, despite this association, there was no increased risk of subsequent development of respiratory disease during the 14-day follow-up period. This field of investigation remains open to further studies that may offer insights into this complex issue.
Supporting information
S1 Table. Primers and probes used in qPCR assays.
https://doi.org/10.1371/journal.pone.0316444.s001
(PDF)
S2 Table. Socio-demographic factors associated with only pneumococcal carriage, only respiratory viruses detection, co-occurrence in 229 children, Veranópolis, Brazil, 2018–2019.
https://doi.org/10.1371/journal.pone.0316444.s002
(PDF)
S3 Table. Frequency of respiratory viruses in children with and without pneumococcal carriage, Veranópolis/RS, Brazil, between 2018 and 2019.
https://doi.org/10.1371/journal.pone.0316444.s003
(PDF)
S4 Table. Frequency of clinical symptoms and diagnosis in medical care within 14 days according to different respiratory viruses, Veranópolis/RS, Brazil, between 2018 and 2019.
https://doi.org/10.1371/journal.pone.0316444.s004
(PDF)
S5 Table. Detection of different respiratory viruses according to seasons, Veranópolis/RS, Brazil, between 2018 and 2019.
https://doi.org/10.1371/journal.pone.0316444.s005
(PDF)
Acknowledgments
We extend our sincere appreciation to all the staff at the Instituto Moriguchi for their cooperation and collaboration. We also thank the Veranópolis Health Department and Hospital São Peregrino Lazziozi for their assistance in collecting information from medical records. Special thanks go to the staff at the Federal University of Health Science of Porto Alegre, particularly Cristiane Bündchen, for providing statistical assistance. We would like to thank Editage (www.editage.com) for English language editing. We are grateful to all the children who participated in the study as well as to the nurses, pediatricians, and community health workers at the Public and Private Health Systems of Veranópolis.
References
- 1. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, et al. incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004. J Infect Dis. 2007;196: 1346–1354. pmid:17922399
- 2. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201: 32–41. pmid:19947881
- 3. Scotta MC, Veras TN, Klein PC, Tronco V, Polack FP, Mattiello R, et al. Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on childhood pneumonia hospitalizations in Brazil two years after introduction. Vaccine. 2014;32: 4495–4499. pmid:24958703
- 4. Berezin EN, Jarovsky D, Cardoso MRA, Mantese OC. Invasive pneumococcal disease among hospitalized children in Brazil before and after the introduction of a pneumococcal conjugate vaccine. Vaccine. 2020;38: 1740–1745. pmid:31874778
- 5.
Pan American Health Organization (PAHO), pneumococcus. [cited 10 Nov 2021]. Available: https://www.paho.org/en/topics/pneumococcus
- 6. Wahl B, O’Brien KL, Greenbaum A, Majumder A, Liu L, Chu Y, et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15. Lancet Glob Health. 2018;6: e744–e757.
- 7. Andrade AL, Afonso ET, Minamisava R, Bierrenbach AL, Cristo EB, Morais-Neto OL, et al. Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: A time-series analysis. PLoS One. 2017;12: e0184204. pmid:28880953
- 8.
DATASUS. Pneumococcal Vaccination. [Internet]. 2017 [cited 2024 April [20]. Available from: http://tabnet.datasus.gov.br/cgi/webtabx.exe?bd_pni/cpnibr.def
- 9. Faden H, Duffy L, Wasielewski R, Wolf J, Krystofik D, Tung Y. Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics. J Infect Dis. 1997;175: 1440–1445. pmid:9180184
- 10. Bogaert D, De Groot R, Hermans PWM. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4: 144–154.
- 11. Levine OS, Farley M, Harrison LH, Lefkowitz L, McGeer A, Schwartz B. Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America. Pediatrics. 1999;103: E28. pmid:10049984
- 12. Dano ID, Ousmane S, Moumouni K, Lagare A, Issa I, Testa J. Risk factors associated with Streptococcus pneumonia carriage in children under five years old with acute respiratory infection in Niger. Pan Afr Med J. 2019;33: 239. pmid:31692895
- 13. Wolter N, Tempia S, Cohen C, Madhi SA, Venter M, Moyes J, et al. High nasopharyngeal pneumococcal density, increased by viral co-infection, is associated with invasive pneumococcal pneumonia. J Infect Dis. 2014;210: 1649–1657. pmid:24907383
- 14. Vissers M, Ahout IM, van den Kieboom CH, van der Gaast-de Jongh CE, Groh L, Cremers AJ, et al. High pneumococcal density correlates with more mucosal inflammation and reduced respiratory syncytial virus disease severity in infants. BMC Infect Dis. 2016;16: 129. pmid:26983753
- 15. DeMuri GP, Gern JE, Eickhoff JC, Lynch SV, Wald ER. Dynamics of Bacterial Colonization With Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis During Symptomatic and Asymptomatic Viral Upper Respiratory Tract Infection. Clin Infect Dis. 2018;66: 1045–1053.
- 16. Howard LM, Zhu Y, Griffin MR, Edwards KM, Williams JV, Gil AI, et al. Nasopharyngeal Pneumococcal Density during Asymptomatic Respiratory Virus Infection and Risk for Subsequent Acute Respiratory Illness. Emerg Infect Dis. 2019;25: 2040–2047. pmid:31625844
- 17. Albrich WC, Madhi SA, Adrian PV, van Niekerk N, Mareletsi T, Cutland C, et al. Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. Clin Infect Dis. 2012;54: 601–609. pmid:22156852
- 18. Brotons P, Bassat Q, Lanaspa M, Henares D, Perez-Arguello A, Madrid L, et al. Nasopharyngeal bacterial load as a marker for rapid and easy diagnosis of invasive pneumococcal disease in children from Mozambique. PLoS One. 2017;12: e0184762. pmid:28910402
- 19. Baggett HC, Watson NL, Deloria Knoll M, Brooks WA, Feikin DR, Hammitt LL, et al. Density of Upper Respiratory Colonization With Streptococcus pneumoniae and Its Role in the Diagnosis of Pneumococcal Pneumonia Among Children Aged <5 Years in the PERCH Study. Clin Infect Dis. 2017;64: S317–S327.
- 20. Howard LM, Fan R, Zhu Y, Griffin MR, Edwards KM, Hartinger S, et al. Nasopharyngeal Pneumococcal Density Is Associated With Viral Activity but Not With Use of Improved Stoves Among Young Andean Children. Open Forum Infect Dis. 2017;4: ofx161. pmid:28929126
- 21. Fan RR, Howard LM, Griffin MR, Edwards KM, Zhu Y, Williams JV, et al. Nasopharyngeal Pneumococcal Density and Evolution of Acute Respiratory Illnesses in Young Children, Peru, 2009–2011. Emerg Infect Dis. 2016;22: 1996–1999. pmid:27767919
- 22. Brealey JC, Chappell KJ, Galbraith S, Fantino E, Gaydon J, Tozer S, et al. Streptococcus pneumoniae colonization of the nasopharynx is associated with increased severity during respiratory syncytial virus infection in young children. Respirology. 2018;23: 220–227.
- 23. Brealey JC, Young PR, Sloots TP, Ware RS, Lambert SB, Sly PD, et al. Bacterial colonization dynamics associated with respiratory syncytial virus during early childhood. Pediatr Pulmonol. 2020;55: 1237–1245. pmid:32176838
- 24. Ampofo K, Bender J, Sheng X, Korgenski K, Daly J, Pavia AT, et al. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics. 2008;122: 229–237. pmid:18676537
- 25. Jiang W, Wu M, Zhou J, Wang Y, Hao C, Ji W, et al. Etiologic spectrum and occurrence of co-infections in children hospitalized with community-acquired pneumonia. BMC Infect Dis. 2017;17: 787. pmid:29262797
- 26. Nolan VG, Arnold SR, Bramley AM, Ampofo K, Williams DJ, Grijalva CG, et al. Etiology and Impact of Co-infections in Children Hospitalized with Community-Acquired Pneumonia. J Infect Dis. 2018;218: 179–188. pmid:29228381
- 27. Choe YJ, Park S, Michelow IC. Co-seasonality and co-detection of respiratory viruses and bacteraemia in children: a retrospective analysis. Clin Microbiol Infect. 2020;26: 1690.e5–1690.e8. pmid:32919073
- 28. Hament JM, Kimpen JL, Fleer A, Wolfs TF. Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol Med Microbiol. 1999;26: 189–195. pmid:10575129
- 29. Ishizuka S, Yamaya M, Suzuki T, Takahashi H, Ida S, Sasaki T, et al. Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells. J Infect Dis. 2003;188: 1928–1939.
- 30. Sajjan U, Wang Q, Zhao Y, Gruenert DC, Hershenson MB. Rhinovirus disrupts the barrier function of polarized airway epithelial cells. Am J Respir Crit Care Med. 2008;178: 1271–1281. pmid:18787220
- 31. Chao Y, Marks LR, Pettigrew MM, Hakansson AP. Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease. Front Cell Infect Microbiol. 2014;4: 194.
- 32. Milucky J, Carvalho MG, Rouphael N, Bennett NM, Talbot HK, Harrison LH, et al. Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015–2016. Vaccine. 2019; 37(8): 1094–1100.
- 33.
CDC. Specimen Collection Guidelines. [s.d.] [cited 12 Nov 2021]. Available: https://www.cdc.gov/urdo/downloads/speccollectionguidelines.pdf
- 34. Gunson RN, Maclean AR, Shepherd SJ, Carman WF. Simultaneous detection and quantitation of cytomegalovirus, Epstein-Barr virus, and adenovirus by use of real-time PCR and pooled standards. J Clin Microbiol. 2009;47: 765–770. pmid:19144801
- 35. Zhang H, Wang Y, Porter E, Lu N, Li Y, Yuan F, et al. development of a multiplex real-time RT-PCR assay for simultaneous detection and differentiation of influenza A, B, C, and D viruses. Diagn Microbiol Infect Dis. 2019;95: 59–66. pmid:31130238
- 36.
CDC. Research Use Only CDC Flu SC2 Multiplex Assay Primers and Probes. 10 Sep 2021 [cited 12 Nov 2021]. Available: https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex-primer-probes.html
- 37. Brandileone M-C de C, Zanella RC, Almeida SCG, Cassiolato AP, Lemos APS de, Salgado MM, et al. Long-term effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in children in Brazil. Vaccine. 2019;37: 5357–5363.
- 38. Jansen RR, Wieringa J, Koekkoek SM, Visser CE, Pajkrt D, Molenkamp R, et al. Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. J Clin Microbiol. 2011;49: 2631–2636. pmid:21543571
- 39. Chonmaitree T, Alvarez-Fernandez P, Jennings K, Trujillo R, Marom T, Loeffelholz MJ, et al. Symptomatic and asymptomatic respiratory viral infections in the first year of life: association with acute otitis media development. Clin Infect Dis. 2015;60: 1–9. pmid:25205769
- 40. Bouzid D, Jordi Vila J, Hansen G, Manissero D, Pareja J, Rao SN, et al. Systematic review on the association between respiratory virus real-time PCR cycle threshold values and clinical presentation or outcomes. J Antimicrob Chemother. 2021;23(76): 33–49.
- 41. Ambrosioni J, Bridevaux P-O, Aubert J-D, Soccal P, Wagner G, Kaiser L. Role of rhinovirus load in the upper respiratory tract and severity of symptoms in lung transplant recipients. J Clin Virol. 2015;64: 1–5. pmid:25728070
- 42. Kenealy T. Sore throat. BMJ Clin Evid [Internet]. 2014 Mar 4;2014. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24589314 pmid:24589314
- 43. Mistik S, Gokahmetoglu S, Balci E, Onuk FA. Sore throat in primary care project: a clinical score to diagnose viral sore throat. Fam Pract. 2015;32(3): 263–8. pmid:25808403
- 44. Harris JM 2nd, Gwaltney JMJr. Incubation periods of experimental rhinovirus infection and illness. Clin Infect Dis. 1996;23(6): 1287–90. pmid:8953073
- 45.
Human parainfluenza viruses (HPIVs) [Internet]. 2021 [cited 2021 Nov 18]. Available from: https://www.cdc.gov/parainfluenza/hcp/clinical.html
- 46.
CDC. Flu Symptoms & Diagnosis [Internet]. 2021 [cited 2021 Nov 18]. Available from: https://www.cdc.gov/flu/symptoms/index.html
- 47. Muhandule Birindwa A, Gonzales-Siles L, Nordén R, Geravandi S, Tumusifu Manegabe J, Morisho L, et al. High bacterial and viral load in the upper respiratory tract of children in the Democratic Republic of the Congo. PLoS One. 2020;15: e0240922. pmid:33119683
- 48. Jacoby P, Watson K, Bowman J, Taylor A, Riley TV, Smith DW, et al. Modelling the co-occurrence of Streptococcus pneumoniae with other bacterial and viral pathogens in the upper respiratory tract. Vaccine. 2007;25: 2458–2464.
- 49. Mohammadi M. Acute respiratory infection in co-infection form of bacteria and virus, human Bocavirus with Streptococcus pneumoniae: A case report. Int. J. Infect. Dis., 2020;7(3): e106476.
- 50. X, Zhen g J, Zhu L, Xu H. Human bocavirus-1 screening in infants with acute lower respiratory tract infection Zhang J. Int. Med. Res., 2021;49(8): 03000605211027739.
- 51. Mackenzie GA, McLellan J, Machuka E, Ndiaye M, Pathirana J, Fombah A, et al. Aetiology of lobar pneumonia determined by multiplex molecular analyses of lung and pleural aspirate specimens in the Gambia: findings from population-based pneumonia surveillance. BMJ Open, 2022;12(3): e056706. pmid:35273059
- 52. Nascimento-Carvalho CM, Cardoso MR, Meriluoto M, Kemppainen K, Kantola K, Ruuskanen O, et al. Human bocavirus infection diagnosed serologically among children admitted to hospital with community-acquired pneumonia in a tropical region. J. Med. Virol. 2012;84(2): 253–8. pmid:22170545
- 53. Beder LB, Hotomi M, Ogami M, Yamauchi K, Shimada J, Billal DS, et al. Clinical and microbiological impact of human bocavirus on children with acute otitis media. Eur J Pediatr. 2009;168: 1365–1372 pmid:19221788
- 54. Pettigrew MM, Marks LR, Kong Y, Gent JF, Roche-Hakansson H, Hakansson AP. Dynamic changes in the Streptococcus pneumoniae transcriptome during transition from biofilm formation to invasive disease upon influenza A virus infection. Infect Immun. 2014;82(11):4607–19.
- 55. Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)—United States. MMWR Morb Mortal Wkly Rep. 2009;58(38):1071–4.
- 56. Jartti T, Lehtinen P, Vuorinen T, Koskenvuo M, Ruuskanen O. Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children. J Med Virol. 2004;72: 695–699. pmid:14981776